Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Elelyso (taliglucerase alfa)

Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Terminated Sterility / contamination Pfizer Inc. NDC 0069-0106-01 D-0995-2020
Class II · Moderate risk

Morphine Sulfate

Lack Of Processing Controls

Terminated cGMP deviation Redline Pharmacy Solutions D-1011-2020
Class II · Moderate risk

Daptomycin

Lack Of Processing Controls

Terminated cGMP deviation Redline Pharmacy Solutions D-1008-2020
Class II · Moderate risk

Morphine Sulfate

Lack Of Processing Controls

Terminated cGMP deviation Redline Pharmacy Solutions D-1007-2020
Class II · Moderate risk

Mesalamine Delayed-Release Tablets

Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.

Terminated Dissolution failure Teva Pharmaceuticals USA NDC 0591-2245-22 D-0862-2020
Class II · Moderate risk

Caduet (amlodipine besylate/atorvastatin calcium)

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Terminated Packaging defect Pfizer Inc. NDC 0069-2160-30 D-0842-2020
Class II · Moderate risk

Caduet (amlodipine besylate/atorvastatin calcium)

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Terminated Packaging defect Pfizer Inc. NDC 0069-2180-30 D-0841-2020
Class II · Moderate risk

Major Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 0904-6730-60 D-0858-2020
Class II · Moderate risk

Leader Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 7000-0036-1 D-0857-2020
Class II · Moderate risk

Fentanyl Citrate Inj.

Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility.

Terminated Packaging defect Pfizer Inc. NDC 00409-9094-12 D-0835-2020

Recalls by year